Skip to main content

OXBRYTA

NDC 72786-102 · Global Blood Therapeutics, Inc, A subsidiary of Pfizer Inc.

Generic nameVoxelotor
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)VOXELOTOR
Strength300 mg/1
Pharmacologic classCytochrome P450 3A4 Inhibitors [MoA], Hemoglobin S Polymerization Inhibitor [EPC], Hemoglobin S Polymerization Inhibitors [MoA]
Marketing categoryNDA

Packages

72786-102-02 — 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-102-02)

72786-102-03 — 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72786-102-03)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72786-101 — Voxelotor, 72786-111 — Voxelotor

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.